Moderna ( MRNA) was one of the big beneficiaries of the Covid pandemic, producing tens of billions of dollars in vaccine ...
Moderna, Inc. (NASDAQ:MRNA) is one of the noteworthy S&P 500 stocks Jim Cramer highlighted. Cramer highlighted that the company is likely to remain unprofitable for “years to come,” as he stated: Next ...
Moderna, Inc. (NASDAQ:MRNA) is one of the stocks in focus on Jim Cramer’s game plan. Cramer finished his game plan with the stock, as he commented: Finally, Friday, we’re going to hear from Moderna, ...
'Mad Money' host Jim Cramer looks back at the S&P 500 winner in January. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results